SEC Freezes Nasdaq Bitcoin Options Approval in Jurisdictional Showdown With CME

The SEC has paused its May approval of Nasdaq's cash-settled bitcoin index options, known as QBTC, and will conduct a full commission review after CME Group challenged the agency's authority to oversee the product. The dispute hinges on a fundamental question: whether bitcoin derivatives fall under SEC or CFTC jurisdiction.

CME filed its challenge on June 11, and the stay has remained in place since then. According to CoinDesk's reporting, CME argues that bitcoin is a commodity, not a security, and therefore options tied directly to its value fall under the CFTC's exclusive jurisdiction. If CME prevails, the SEC would lose authority to approve QBTC entirely, forcing Nasdaq either to register as a CFTC-regulated futures or swaps venue or redesign the contracts to track a security such as a spot bitcoin exchange-traded fund.

Nasdaq's May approval envisioned the CFTC granting exemptions that would allow Nasdaq and the Options Clearing Corporation to offer the product through the securities market. CME contested this approach, arguing that agencies cannot use exemptions to transfer regulatory authority from one regulator to another. CME also warned that the approval could set a precedent allowing securities exchanges to list derivatives on other commodities, potentially fragmenting oversight.

The stakes extend beyond QBTC. CME already operates regulated bitcoin futures and options markets. If Nasdaq launches a competing product without CFTC registration, it would create an unregulated competitor to CME's established platforms, all of which use CME CF benchmarks for both their underlying index and final settlement price, per the reporting.

Nasdaq's QBTC remains suspended while the full SEC commission reviews the earlier approval. Interested parties have until August 24 to submit statements supporting or opposing the decision. No timeline has been announced for the SEC's final ruling on the jurisdictional question.